Literature DB >> 1800581

Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T cells.

V Holán1, K Kohno, J Minowada.   

Abstract

The production of interleukin-2 (IL-2) by Concanavalin A (ConA)-stimulated peripheral blood leukocytes (PBL) from normal human donors was enhanced by natural human interferon-alpha (IFN-alpha). The mechanism of the action of IFN-alpha on IL-2 production was studied further using cloned human leukemic T-cell lines, which produce IL-2 spontaneously and/or after mitogen stimulation. It was found that IFN-alpha alone did not stimulate IL-2 production, but increased it in the activated cells. The ability of IFN-alpha to increase IL-2 production was abrogated by the treatment of IFN-alpha preparations with specific anti-IFN-alpha antibody, and the induced IL-2 activity was completely inhibited by monoclonal antibody against human IL-2. We suggest that the augmentation by IFN-alpha of IL-2 production in the activated T cells may be one of the mechanisms attributable to the immunotherapeutic action of IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800581     DOI: 10.1089/jir.1991.11.319

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

Review 1.  Alpha interferon as an immunomodulator in the treatment of patients with tumors.

Authors:  M Alvarez-Mon; O J Salmerón; L Manzano; M Rodríguez-Zapata; E Reyes; L M Vaquer; J Carballido
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

2.  Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.

Authors:  J Ferbas; J Navratil; A Logar; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

3.  Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations.

Authors:  V Holán; S Nakamura; J Minowada
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 4.  Prognostic factors for biologic therapy in kidney cancer.

Authors:  Beverly J Drucker
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.